STOCK TITAN

Genesco Financials

GCO
Source SEC Filings (10-K/10-Q) Updated Jan 31, 2026 Currency USD FYE January

This page shows Genesco (GCO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GCO FY2026

Working-capital release and a near-debt-free balance sheet powered the recovery, while core profitability stayed unusually thin.

FY2026’s return to profit was driven more by cash conversion than by margin repair: operating cash flow reached $145.8M against net income of just $13.3M, while inventory and receivables both fell from FY2025. That working-capital release helped lift free cash flow to $83.7M even though gross margin remained below FY2022 and operating margin was only 0.7%.

Sales are back near FY2022 levels, but profit structure has not recovered: gross margin fell from 48.8% to 46.3% across that span. With SG&A still around $1.10B, even a modest squeeze in merchandise margin now has an outsized effect on operating income.

The balance sheet is materially less leveraged than a year ago because long-term debt fell from $113.7M to $3.4M. Cash also rose to $105.4M, which means the business is relying less on borrowing and more on internally generated cash despite still-thin earnings.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 38 / 100
Financial Profile 38/100

Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Genesco's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
23

Genesco has an operating margin of 0.7%, meaning the company retains $1 of operating profit per $100 of revenue. This below-average margin results in a low score of 23/100, suggesting thin profitability after operating expenses. This is up from 0.6% the prior year.

Growth
37

Genesco's revenue grew a modest 4.8% year-over-year to $2.4B. This slow but positive growth earns a score of 37/100.

Leverage
100

Genesco carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
29

Genesco's current ratio of 1.64 is below the typical benchmark, resulting in a score of 29/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
32

Genesco has a free cash flow margin of 3.4%, earning a moderate score of 32/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
10

Genesco generates a 2.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 10/100. This is up from -3.6% the prior year.

Altman Z-Score Grey Zone
2.55

Genesco scores 2.55, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Strong
7/9

Genesco passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
10.99x

For every $1 of reported earnings, Genesco generates $10.99 in operating cash flow ($145.8M OCF vs $13.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
4.2x

Genesco earns $4.2 in operating income for every $1 of interest expense ($17.3M vs $4.1M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.4B
YoY+4.8%
5Y CAGR+6.4%
10Y CAGR-2.1%

Genesco generated $2.4B in revenue in fiscal year 2026. This represents an increase of 4.8% from the prior year.

EBITDA
$70.6M
YoY+6.4%
10Y CAGR-11.1%

Genesco's EBITDA was $70.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.4% from the prior year.

Net Income
$13.3M
YoY+170.2%
10Y CAGR-17.8%

Genesco reported $13.3M in net income in fiscal year 2026. This represents an increase of 170.2% from the prior year.

EPS (Diluted)
$1.25
YoY+171.8%
10Y CAGR-11.2%

Genesco earned $1.25 per diluted share (EPS) in fiscal year 2026. This represents an increase of 171.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$83.7M
YoY+79.0%
5Y CAGR-8.9%
10Y CAGR+5.5%

Genesco generated $83.7M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 79.0% from the prior year.

Cash & Debt
$105.4M
YoY+384.7%
5Y CAGR-16.4%
10Y CAGR+9.4%

Genesco held $105.4M in cash against $3.4M in long-term debt as of fiscal year 2026.

Dividends Per Share
N/A
Shares Outstanding
11M
YoY-1.6%
5Y CAGR-6.2%
10Y CAGR-6.5%

Genesco had 11M shares outstanding in fiscal year 2026. This represents a decrease of 1.6% from the prior year.

Margins & Returns

Gross Margin
46.3%
YoY-0.9pp
5Y CAGR+1.2pp
10Y CAGR-1.5pp

Genesco's gross margin was 46.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the prior year.

Operating Margin
0.7%
YoY+0.1pp
5Y CAGR+6.7pp
10Y CAGR-4.3pp

Genesco's operating margin was 0.7% in fiscal year 2026, reflecting core business profitability. This is up 0.1 percentage points from the prior year.

Net Margin
0.5%
YoY+1.4pp
5Y CAGR+3.7pp
10Y CAGR-2.6pp

Genesco's net profit margin was 0.5% in fiscal year 2026, showing the share of revenue converted to profit. This is up 1.4 percentage points from the prior year.

Return on Equity
2.3%
YoY+6.0pp
5Y CAGR+12.1pp
10Y CAGR-8.1pp

Genesco's ROE was 2.3% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 6.0 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$12.6M
YoY+28.4%
10Y CAGR-21.5%

Genesco spent $12.6M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 28.4% from the prior year.

Capital Expenditures
$62.1M
YoY+50.9%
5Y CAGR+20.8%
10Y CAGR-4.7%

Genesco invested $62.1M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 50.9% from the prior year.

GCO Income Statement

Metric Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25
Revenue $616.2M+12.9% $546.0M+15.2% $474.0M-35.0% $729.6M+22.3% $596.3M+13.5% $525.2M+14.8% $457.6M-40.2% $764.7M
Cost of Revenue $327.6M+10.7% $296.0M+17.1% $252.8M-34.3% $384.8M+23.7% $311.1M+11.3% $279.5M+15.8% $241.3M-41.2% $410.1M
Gross Profit $288.6M+15.5% $249.9M+13.0% $221.2M-35.8% $344.7M+20.9% $285.3M+16.1% $245.6M+13.6% $216.3M-39.0% $354.6M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $275.7M+4.3% $264.3M+6.1% $249.0M-17.1% $300.6M+9.3% $274.9M+7.8% $255.1M+2.9% $247.8M-19.3% $307.2M
Operating Income $8.6M+159.4% -$14.4M+48.7% -$28.1M-166.8% $42.1M+312.7% $10.2M+199.4% -$10.3M+68.0% -$32.1M-169.2% $46.4M
Interest Expense -$884K+39.4% -$1.5M-9.0% -$1.3M+75.5% -$5.5M-550.9% $1.2M-9.8% $1.3M+51.1% $890K-61.3% $2.3M
Income Tax $2.1M-12.0% $2.4M+128.5% -$8.5M-174.9% $11.3M-59.3% $27.8M+1663.0% -$1.8M+79.9% -$8.8M-148.3% $18.3M
Net Income $5.4M+129.0% -$18.5M+13.0% -$21.2M-167.9% $31.3M+265.1% -$18.9M-89.5% -$10.0M+59.0% -$24.3M-174.6% $32.6M
EPS (Diluted) $0.50+127.9% $-1.79+11.4% $-2.02 N/A $-1.76-93.4% $-0.91+59.2% $-2.23 N/A

GCO Balance Sheet

Metric Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25
Total Assets $1.5B+3.5% $1.4B+1.2% $1.4B+5.2% $1.3B-7.0% $1.4B+3.7% $1.4B+5.8% $1.3B-1.7% $1.3B
Current Assets $689.1M+6.7% $645.9M+2.0% $633.3M+4.0% $608.8M-7.7% $659.7M+8.7% $606.7M+19.4% $508.0M+0.1% $507.4M
Cash & Equivalents $27.0M-34.0% $41.0M+88.5% $21.7M-36.0% $34.0M+1.3% $33.6M-26.8% $45.9M+138.2% $19.2M-45.3% $35.2M
Inventory $558.1M+11.4% $501.0M+11.1% $450.8M+6.0% $425.2M-18.7% $523.2M+16.2% $450.2M+14.6% $392.7M+3.6% $379.0M
Accounts Receivable $55.8M+2.8% $54.3M+2.9% $52.8M+8.1% $48.9M-6.7% $52.4M-8.9% $57.5M+14.7% $50.1M-6.5% $53.6M
Goodwill $9.2M0.0% $9.2M-1.5% $9.3M+5.1% $8.9M-4.0% $9.2M-0.6% $9.3M-1.4% $9.4M-1.5% $9.6M
Total Liabilities $958.3M+4.7% $915.6M+3.8% $882.4M+11.9% $788.6M-14.2% $918.6M+7.9% $851.1M+12.1% $759.0M0.0% $758.7M
Current Liabilities $436.0M+5.2% $414.4M+25.2% $330.9M-12.9% $379.8M-10.0% $422.1M+6.7% $395.7M+28.4% $308.2M-3.6% $319.5M
Long-Term Debt $69.8M+21.0% $57.7M-49.3% $113.7M $0-100.0% $100.1M+28.6% $77.8M+30.9% $59.4M+71.4% $34.7M
Total Equity $513.8M+1.5% $506.4M-3.0% $522.2M-4.5% $547.0M+5.8% $516.9M-3.0% $532.6M-2.9% $548.5M-4.0% $571.2M
Retained Earnings $218.3M+2.5% $213.0M-8.2% $232.0M-12.7% $265.9M+14.6% $232.0M-7.7% $251.4M-7.5% $271.6M-8.5% $296.8M

GCO Cash Flow Statement

Metric Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25
Operating Cash Flow -$12.9M-114.9% $86.3M+185.5% -$101.0M-186.4% $117.0M+606.9% -$23.1M-183.3% $27.7M+182.1% -$33.7M-128.5% $118.3M
Capital Expenditures $18.6M+26.7% $14.7M-22.3% $18.9M+37.6% $13.7M+4.7% $13.1M+66.2% $7.9M+23.8% $6.4M-39.6% $10.6M
Free Cash Flow -$31.5M-144.0% $71.7M+159.8% -$119.9M-216.1% $103.3M+385.2% -$36.2M-282.7% $19.8M+149.4% -$40.1M-137.2% $107.8M
Investing Cash Flow -$18.6M-26.7% -$14.7M+22.3% -$18.9M-37.6% -$13.7M-4.7% -$13.1M-66.2% -$7.9M-23.8% -$6.4M+38.4% -$10.3M
Financing Cash Flow $17.5M+133.5% -$52.4M-148.9% $107.3M+205.7% -$101.5M-529.9% $23.6M+253.6% $6.7M-72.4% $24.2M+125.6% -$94.8M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks $0 $0-100.0% $12.6M $0-100.0% $440K-95.3% $9.3M $0 $0

GCO Financial Ratios

Metric Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25
Gross Margin 46.8%+1.1pp 45.8%-0.9pp 46.7%-0.6pp 47.3%-0.6pp 47.8%+1.1pp 46.8%-0.5pp 47.3%+0.9pp 46.4%
Operating Margin 1.4%+4.0pp -2.6%+3.3pp -5.9%-11.7pp 5.8%+4.1pp 1.7%+3.7pp -2.0%+5.1pp -7.0%-13.1pp 6.1%
Net Margin 0.9%+4.3pp -3.4%+1.1pp -4.5%-8.8pp 4.3%+7.4pp -3.2%-1.3pp -1.9%+3.4pp -5.3%-9.6pp 4.3%
Return on Equity 1.0%+4.7pp -3.6%+0.4pp -4.1%-9.8pp 5.7%+9.4pp -3.7%-1.8pp -1.9%+2.6pp -4.4%-10.2pp 5.7%
Return on Assets 0.4%+1.7pp -1.3%+0.2pp -1.5%-3.9pp 2.3%+3.7pp -1.3%-0.6pp -0.7%+1.1pp -1.9%-4.3pp 2.5%
Current Ratio 1.58+0.0 1.56-0.4 1.91+0.3 1.60+0.0 1.56+0.0 1.53-0.1 1.65+0.1 1.59
Debt-to-Equity 0.14+0.0 0.11-0.1 0.22+0.2 0.00-0.2 0.19+0.0 0.15+0.0 0.11+0.0 0.06
FCF Margin -5.1%-18.2pp 13.1%+38.4pp -25.3%-39.4pp 14.1%+20.2pp -6.1%-9.8pp 3.8%+12.5pp -8.8%-22.9pp 14.1%

Similar Companies

Frequently Asked Questions

Genesco (GCO) reported $2.4B in total revenue for fiscal year 2026. This represents a 4.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Genesco (GCO) revenue grew by 4.8% year-over-year, from $2.3B to $2.4B in fiscal year 2026.

Yes, Genesco (GCO) reported a net income of $13.3M in fiscal year 2026, with a net profit margin of 0.5%.

Genesco (GCO) reported diluted earnings per share of $1.25 for fiscal year 2026. This represents a 171.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Genesco (GCO) had EBITDA of $70.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, Genesco (GCO) had $105.4M in cash and equivalents against $3.4M in long-term debt.

Genesco (GCO) had a gross margin of 46.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Genesco (GCO) had an operating margin of 0.7% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Genesco (GCO) had a net profit margin of 0.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Genesco (GCO) has a return on equity of 2.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Genesco (GCO) generated $83.7M in free cash flow during fiscal year 2026. This represents a 79.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Genesco (GCO) generated $145.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Genesco (GCO) had $1.4B in total assets as of fiscal year 2026, including both current and long-term assets.

Genesco (GCO) invested $62.1M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Yes, Genesco (GCO) spent $12.6M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Genesco (GCO) had 11M shares outstanding as of fiscal year 2026.

Genesco (GCO) had a current ratio of 1.64 as of fiscal year 2026, which is generally considered healthy.

Genesco (GCO) had a debt-to-equity ratio of 0.01 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Genesco (GCO) had a return on assets of 0.9% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Genesco (GCO) has an Altman Z-Score of 2.55, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Genesco (GCO) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Genesco (GCO) has an earnings quality ratio of 10.99x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Genesco (GCO) has an interest coverage ratio of 4.2x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Genesco (GCO) scores 38 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top